Kidney disease can be either acute kidney injury (AKI) or chronic kidney disease (CKD) and
it can lead to the development of functional organ failure. Mesenchymal stem cells (MSCs) …

Mesenchymal stem cells (MSCs) are now known to display not only stem cell multipotency,
but also robust antiinflammatory and regenerative properties. After widespread in-vitro and …

Background Bio-products from stem/progenitor cells, such as extracellular vesicles, are
likely a new promising approach for reprogramming resident cells in both acute and chronic …

This study evaluated the effects of bone marrow-derived mesenchymal stem cells (BMSCs)
or their conditioned medium (CM) on the repair and prevention of Acute Kidney Injury (AKI) …

Chronic kidney disease (CKD) is a major health care problem, affecting more than 35% of
the elderly population worldwide. New interventions to slow or prevent disease progression …

Introduction Administration of mesenchymal stem cells (MSCs) has been shown to improve
renal function in rodent models of chronic kidney disease (CKD), in part by reducing …

Diabetic nephropathy (DN) is a major complication of diabetes and represents the leading
cause of end-stage renal disease. Mesenchymal stem cell (MSC) treatment has been …

Objectives Feline chronic kidney disease (CKD) is characterized by chronic tubulointerstitial
nephritis, and inflammation contributes to the progression of renal fibrosis. Mesenchymal …

Allogeneic mesenchymal stem cell transplantation (MSCT) has been shown to be clinically
efficacious in the treatment of various autoimmune diseases. Here, we analyzed the role of …

Cell-based therapy is a promising strategy for treating chronic kidney disease (CKD) and is
currently the focus of preclinical studies. We performed a systematic review and meta …